Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN72853206
ISRCTN72853206
Completed
未知

Intra-coronary transfusion of autologous CD34+ cells improves left ventricular function in patients with diffuse coronary artery disease and non candidates for coronary artery intervention: a randomised controlled trial

ational Science Council (Taiwan)0 sites38 target enrollmentFebruary 17, 2012
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsChronic ischemic heart diseaseCirculatory SystemChronic ischaemic heart disease, unspecified

Overview

Phase
未知
Intervention
Not specified
Conditions
Chronic ischemic heart disease
Sponsor
ational Science Council (Taiwan)
Enrollment
38
Status
Completed
Last Updated
5 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

2015 results in https://pubmed.ncbi.nlm.nih.gov/26154930/ (added 17/12/2020) 2020 results in https://pubmed.ncbi.nlm.nih.gov/32727585/ (added 17/12/2020)

Registry
who.int
Start Date
February 17, 2012
End Date
December 1, 2014
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
ational Science Council (Taiwan)

Eligibility Criteria

Inclusion Criteria

  • •1\. Patients aged 20\-80
  • •2\. Have angina pectoris resulted in severely and diffusely atherosclerotic\-obstructive CAD with refractory to optimal medication not the candidates for both PCI or CABG

Exclusion Criteria

  • •1\. Age \<20 years or \> 80 years
  • •2\. Pregnant women
  • •3\. Patients with adventitious agents \[like:Human immunodeficiency virus (HIV), Hepatitis viruses]
  • •4\. Recent myocardial infarction (MI) within 3 months
  • •5\. Aortic stenosis or mitral stenosis
  • •6\. Congestive heart failure
  • •7\. New York Heart Association Functional Class IV (NYHA Fc.IV)
  • •8\. Malignancy or other severe disease with life span less than one year
  • •9\. Chronic kidney disease with creatinine clearance (CCr) \<20ml/min and end stage renal disease

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Intra-coronary transfusion of autologous CD34+ cells improves left ventricular function in patients with diffuse coronary artery disease (CAD) and non-candidates for coronary artery interventio
ISRCTN26002902ational Science Council (Taiwan)60
Completed
Phase 1
Autologous peripheral blood-derived CD34+ cell transplantation for acute kidney injury.acute kidney injury
JPRN-UMIN000031691Kidney Disease and Transplant Center, Shonan Kamakura General Hospital9
Completed
Phase 1
A Phase I/ II Clinical Trial: Autologous CD34+ Cell Transplantation for Bone and Vascular Healing in Patients with Non-Union Fractureon-Union Fracture
JPRN-UMIN000002993Ryosuke Kuroda, M.D., Ph.D.17
Active, not recruiting
Phase 1
A study testing a gene therapy to treat mucopolysaccharidosis type IIIA (MPS IIIA, Sanfilippo syndrome type A)
EUCTR2019-002051-42-GBniversity of Manchester5
Completed
Phase 1
CD133+ Autologous Cells After Myocardial InfarctionAcute Myocardial Infarction
NCT00400959Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico15